TG Therapeutics gets USFDA Orphan Drug Designation for follicular lymphoma drug Umbralisib Medical Dialogues Bureau9 March 2020 5:15 AM GMTNew York - TG Therapeutics, Inc.today announced that the U.S. Food and Drug Administration (FDA) granted orphan drug designation to umbralisib,...